Novel heterologous listeria-adenovirus mucosal vaccine for HIV-1
针对 HIV-1 的新型异源李斯特菌腺病毒粘膜疫苗
基本信息
- 批准号:7915872
- 负责人:
- 金额:$ 80万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-17 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS VaccinesAIDS vaccine developmentAbsence of pain sensationAcquired Immunodeficiency SyndromeAddressAdenovirus VectorAdenovirusesAdjuvantAffectAfricaAgreementAlcoholsAliquotAmendmentAnalgesicsAnesthesia proceduresAnestheticsAnimal Care and Use CommitteesAnimal ExperimentationAnimal ExperimentsAnimal FeedAnimal HousingAnimal ModelAnimal Use AlternativesAnimal WelfareAnimal Welfare ActAnimalsAnorexiaAntibioticsAntibody FormationAntigensAnusApplications GrantsAppointmentAreaAscitesAttenuatedAuthorization documentationAwardAxillaBackBacteriaBandageBathingBehaviorBehavior ControlBiologicalBiological AssayBiomedical ResearchBiopsyBiopsy SpecimenBirdsBloodBlood VesselsBlood specimenBody FluidsBody WeightBody Weight decreasedBostonBoxingBreedingBronchiBronchoalveolar LavageBronchoscopesBudgetsBuprenexBuprenorphineBurn injuryBusinessesCalendarCapsidCardiacCaringCategoriesCathetersCause of DeathCellsCellular ImmunityCellular ImmunologyCertificationCervicalCervix UteriCessation of lifeChairpersonChildhoodClinicalClinical ResearchClinical TrialsCollaborationsCollectionColorectalCommitCommittee MembersCommunicationComplement component C1sConfidential InformationConsultConsultationsCountryCulture MediaDNADNA VaccinesDNA vaccine-elicited immunityDataDevelopmentDevicesDiarrheaDietDirect CostsDisclosureDiseaseDissectionDistressDoctor of PhilosophyDorsalDoseDrug FormulationsDuct (organ) structureDuodenumEducational process of instructingEffectivenessElectrodesElectronic MailElectronicsElectroporationEmployeeEndoscopesEndoscopic BiopsyEngineeringEpidemicEquipmentEuthanasiaEventExcisionExerciseExhibitsExperimental Water DeprivationFaceFacilities and Administrative CostsFacultyFailureFastingFellowshipFemoral veinFlow CytometryFlushingFoodForcepFormalinFoundationsFrequenciesFringe BenefitFundingFunding AgencyGenital systemGenotypeGenus MycobacteriumGoalsGoldGovernmentGrantGuidelinesHIVHIV AntigensHIV InfectionsHIV vaccineHIV-1HIV-1 vaccineHIV/SIV vaccineHandHeadHealth InsuranceHealth PrioritiesHemorrhageHemostatic functionHeterosexualsHistopathologyHome environmentHourHousingHumanHuman ResourcesHybridomasIACUCIceImageImmuneImmune responseImmune systemImmunityImmunizationImmunologyImmunology procedureImpairmentIn VitroIncomeIndividualInfantInfectionInjection of therapeutic agentInjuryInpatientsInstitutesInstitutionInstructionIntraperitoneal InjectionsInvestmentsIrrigationIsraelJapanKetamineKetamine HydrochlorideKnock-outLaboratoriesLaboratory AnimalsLanguageLaryngoscopesLarynxLateralLawsLeadLeftLettersLidocaineLifeLife Cycle StagesLightLiquid substanceListeriaListeria monocytogenesLiteratureLocationLungLymphocyteMacaca mulattaMagnetic Resonance ImagingMailsMaintenanceManualsMarketingMediationMedicalMedical centerMedicineMethodsMicrobiologyMinorModelingModificationMolecularMolecular BiologyMolecular ConformationMonitorMonkeysMucosal Immune ResponsesMucosal ImmunityMucous MembraneMusMuscleNIH Vaccine Research CenterNamesNational Institute of Allergy and Infectious DiseaseNatureNeedlesNeurologicORALITOperative Surgical ProceduresOpportunistic InfectionsOralOral mucous membrane structureOrganOutpatientsOvumPainParalysedPathogenesisPatient CarePelvisPennsylvaniaPeripheralPersonal SatisfactionPersonsPharmaceutical PreparationsPhase I Clinical TrialsPhenotypePhiladelphiaPhysiologic pulsePilot ProjectsPlasmaPlasticsPoisonPoliciesPoriferaPositioning AttributePostdoctoral FellowPostoperative PeriodPovidone-IodinePoxviridaePreparationPrimatesPrincipal InvestigatorPrintingProceduresProcessProductionProgress ReportsProteinsProtocols documentationPublic HealthQuarantineQuestionnairesRadioisotopesReadingReagentRecombinant DNARecombinant ProteinsRecombinantsRegulationRegulatory AffairsReportingResearchResearch PersonnelResearch SubjectsResearch SupportResponse ElementsRiotsRisk AssessmentRodentRoleRouteSIVSafetySalineSamplingScheduleSchoolsScienceScientistSerotypingServicesShockSignal TransductionSiteSkinSocietiesSonSourceSpecialistSpecimenSpeculumsSterilityStimulusStomachStructure of pyloric ostium of stomachSumSupervisionSurgical incisionsSyringesSystems BiologyT-LymphocyteTechniquesTechnologyTelazolTelefacsimileTelephoneTestingTimeTissue HarvestingTissue and Organ HarvestingTissuesToxinTracheaTrainingTranquilizing AgentsTransgenic MiceTransgenic OrganismsTraumaTravelTreatment ProtocolsTubeU-Series Cooperative AgreementsUnited States National Institutes of HealthUniversitiesUpdateUrineVaccinatedVaccinationVaccinesVaginaVariantVeinsVenipuncturesVeterinariansVicrylViralViral PathogenesisViral VectorVirusWagesWalkersWalkingWeightWitWomanWorkWritingabsorptionabstractinganimal careauthoritybasebehavior observationchemical carcinogenchiron vaccineclinical efficacyconformercostdesignenvironmental changeexperienceexpirationfeedingflexibilitygastrointestinalhuman subjectimmunogenicimmunogenicityimplantationimprovedin vivoinhibitor/antagonistinstrumentinterestintravenous injectionirradiationjejunumlymph nodesmedical schoolsmeetingsmicrobicidemicroorganismmucosal sitemucosal vaccinationmucosal vaccinenanoparticleneutralizing antibodynonhuman primatenovelnovel strategiespandemic diseasepathogenpediatric AIDSpediatric human immunodeficiency viruspeerpoxvirus vectorspre-clinicalpreclinical evaluationpreclinical studyprofessorprogramsprotective efficacypublic health relevancerectalresearch clinical testingresearch studyresponserestraintskillssymposiumtext searchingtissue culturetransmission processtumoruptakevaccine candidatevaccine deliveryvaccinologyvectorvector vaccinevector-based vaccineviral RNAvocal cordweb site
项目摘要
. Project Summary/Abstract
AIDS continues to be an expanding pandemic. The successful development of a
safe and effective HIV vaccine is a global health priority that has been hampered by our
current inability to deliver HIV antigens efficiently to the immune system to prime
predictable, high frequency, and durable immune responses in humans. To approach
this problem, we propose a unique prime-boost vaccine strategy that pairs two live
mucosal vectors, Listeria monocytogenes (Listeria, Lm) and adenovirus (Ad), each of
which has been tested in clinical trials in humans, and both have shown the ability in
small animal models and NHP to elicit strong cellular immunity. The proposal is
provoked by our recent observations that mucosal administration of attenuated Listeria
followed by a boost by replication-incompetent Ad5 elicited potent peripheral and
mucosal T cell responses, and by the development of new Ad variants that circumvent
anti-Ad5 immunity. Because most HIV infections result from heterosexual transmission
to women, and because the virus targets lymphocytes in the gut and vaginal mucosae
for rapid elimination, this project aims by use of these vectors to strengthen immunity
and protection at these important mucosal sites. The laboratories of Drs. Dan Barouch
at Beth Isreal Deaconess Medical Center and Fred Frankel at the University of
Pennsylvania School of Medicine will collaborate to explore the potential synergy of
these two vectors. Dr. Frankel will examine vector interactions in mice, while Dr.
Barouch will conduct concurrent pilot studies testing these vectors in the nonhuman
primate model.
. 项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fred Robert Frankel其他文献
Fred Robert Frankel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fred Robert Frankel', 18)}}的其他基金
Vaginal Immunity After Intranasal Listeria Vaccination
鼻内李斯特菌疫苗接种后的阴道免疫力
- 批准号:
7933238 - 财政年份:2007
- 资助金额:
$ 80万 - 项目类别:
Vaginal Immunity After Intranasal Listeria Vaccination
鼻内李斯特菌疫苗接种后的阴道免疫力
- 批准号:
7334102 - 财政年份:2007
- 资助金额:
$ 80万 - 项目类别:
Vaginal Immunity After Intranasal Listeria Vaccination
鼻内李斯特菌疫苗接种后的阴道免疫力
- 批准号:
7472543 - 财政年份:2007
- 资助金额:
$ 80万 - 项目类别:
Optimizing Listeria for use as an HIV Vaccine
优化李斯特菌作为 HIV 疫苗的用途
- 批准号:
6511293 - 财政年份:2001
- 资助金额:
$ 80万 - 项目类别:
Optizimizing Listeria for use as an HIV Vaccine
优化李斯特菌作为 HIV 疫苗的用途
- 批准号:
6346487 - 财政年份:2001
- 资助金额:
$ 80万 - 项目类别:
SAFE VACCINE STRAIN OF LISTERIA MONOCYTOGENES FOR HIV
艾滋病毒单核细胞增生李斯特氏菌的安全疫苗株
- 批准号:
6163938 - 财政年份:1998
- 资助金额:
$ 80万 - 项目类别:
SAFE VACCINE STRAIN OF LISTERIA MONOCYTOGENES FOR HIV
艾滋病毒单核细胞增生李斯特氏菌的安全疫苗株
- 批准号:
2649221 - 财政年份:1998
- 资助金额:
$ 80万 - 项目类别:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
一种安全的艾滋病毒单核细胞增生李斯特菌疫苗株
- 批准号:
6494977 - 财政年份:1998
- 资助金额:
$ 80万 - 项目类别:
A Safe Vaccine Strain of Listeria Monocytogenes for HIV
一种安全的艾滋病毒单核细胞增生李斯特菌疫苗株
- 批准号:
6706359 - 财政年份:1998
- 资助金额:
$ 80万 - 项目类别:
相似海外基金
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10610268 - 财政年份:2022
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10383109 - 财政年份:2021
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9915686 - 财政年份:2019
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
10818316 - 财政年份:2018
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9467403 - 财政年份:2017
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9259797 - 财政年份:2016
- 资助金额:
$ 80万 - 项目类别:
Reagent Resource Support Program for AIDS Vaccine Development
艾滋病疫苗研发试剂资源支持计划
- 批准号:
9050566 - 财政年份:2015
- 资助金额:
$ 80万 - 项目类别:














{{item.name}}会员




